Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

NCT03402295 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

311

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma
Effects of Chemotherapy

Interventions

DRUG: Bortezomib, cyclophosphamide, thalidomide, dexamethasone

Sponsor

Grupo de Estudos Multicentricos em Onco-Hematologia